{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T05:42:38Z","timestamp":1744177358569},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2009,10,23]],"date-time":"2009-10-23T00:00:00Z","timestamp":1256256000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med Microbiol Immunol"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1007\/s00430-009-0130-9","type":"journal-article","created":{"date-parts":[[2009,10,22]],"date-time":"2009-10-22T04:16:47Z","timestamp":1256185007000},"page":"205-209","source":"Crossref","is-referenced-by-count":8,"title":["Possible hidden hazards of mass vaccination against new influenza A\/H1N1: have the cardiovascular risks been adequately weighed?"],"prefix":"10.1007","volume":"198","author":[{"given":"Sucharit","family":"Bhakdi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karl","family":"Lackner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans-Wilhelm","family":"Doerr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,10,23]]},"reference":[{"key":"130_CR1","unstructured":"Chan M (2009) World now at the start of 2009 influenza pandemic: http:\/ www.who.int\/mediacentre\/news\/statements\/2009\/h1n1_pandemic_phase6_20090611\/en\/index.html . Statement to the press by WHO Director General Dr Margaret Chan; WHO, 11. Juni 2009"},{"key":"130_CR2","unstructured":"WHO (2009) WHO pandemic phase description and main actions by phase. http:\/\/www.who.int\/csr\/disease\/influenza\/GIPA3AideMemoire.pdf"},{"key":"130_CR3","unstructured":"CDC CfDCaP (2009) 2009 H1N1 Flu: international situation update. http:\/\/www.cdc.gov\/h1n1flu\/updates\/international\/"},{"key":"130_CR4","unstructured":"ACIP (2009) Use of influenza A (H1N1) 2009 monovalent vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR Recomm Rep 58:1\u20138 http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=19713882"},{"key":"130_CR5","doi-asserted-by":"crossref","unstructured":"Neuzil KM (2009) Pandemic influenza vaccine policy\u2014considering the early evidence. N Engl J Med http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=19745213","DOI":"10.1056\/NEJMe0908224"},{"key":"130_CR6","unstructured":"Reed S (2009) Brief overview of use of oil-in-water emulsions as adjuvants for influenza vaccines. http:\/ www.who.int\/vaccine_research\/documents\/Brief_overview_of_use_of_oil-in-water_emulsions.pdf"},{"key":"130_CR7","unstructured":"Clark TW, Pareek M, Hoschler K, Dillon H, Nicholson KG, Groth N, Stephenson I (2009) Trial of influenza A (H1N1) 2009 monovalent MF59-adjuvanted vaccine\u2014preliminary report. N Engl J Med http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=19745215"},{"key":"130_CR8","doi-asserted-by":"crossref","first-page":"5402","DOI":"10.4049\/jimmunol.180.8.5402","volume":"180","author":"A Seubert","year":"2008","unstructured":"Seubert A, Monaci E, Pizza M, O\u2019Hagan DT, Wack A (2008) The adjuvants aluminum hydroxide and MF59 induce monocyte and granulocyte chemoattractants and enhance monocyte differentiation toward dendritic cells. J Immunol 180:5402\u20135412","journal-title":"J Immunol"},{"key":"130_CR9","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/S0140-6736(07)61297-5","volume":"370","author":"I Leroux-Roels","year":"2007","unstructured":"Leroux-Roels I, Borkowski A, Vanwolleghem T, Drame M, Clement F, Hons E, Devaster JM, Leroux-Roels G (2007) Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: a randomised controlled trial. Lancet 370:580\u2013589","journal-title":"Lancet"},{"key":"130_CR10","doi-asserted-by":"crossref","unstructured":"Lehr HA, Sagban TA, Ihling C, Zahringer U, Hungerer KD, Blumrich M, Reifenberg K, Bhakdi S (2001) Immunopathogenesis of atherosclerosis: endotoxin accelerates atherosclerosis in rabbits on hypercholesterolemic diet. Circulation 104:914\u2013920 http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=&db=PubMed&dopt=Citation&list_uids=11514379","DOI":"10.1161\/hc3401.093153"},{"key":"130_CR11","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1160\/TH03-12-0733","volume":"91","author":"S Bhakdi","year":"2004","unstructured":"Bhakdi S, Lackner KJ, Han SR, Torzewski M, Husmann M (2004) Beyond cholesterol: the enigma of atherosclerosis revisited. Thromb Haemost 91:639\u2013645","journal-title":"Thromb Haemost"},{"key":"130_CR12","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1056\/NEJMoa012673","volume":"347","author":"S Kiechl","year":"2002","unstructured":"Kiechl S, Lorenz E, Reindl M, Wiedermann CJ, Oberhollenzer F, Bonora E, Willeit J, Schwartz DA (2002) Toll-like receptor 4 polymorphisms and atherogenesis. N Engl J Med 347:185\u2013192","journal-title":"N Engl J Med"},{"key":"130_CR13","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1189\/jlb.1206751","volume":"82","author":"K Herold","year":"2007","unstructured":"Herold K, Moser B, Chen Y, Zeng S, Yan SF, Ramasamy R, Emond J, Clynes R, Schmidt AM (2007) Receptor for advanced glycation end products (RAGE) in a dash to the rescue: inflammatory signals gone awry in the primal response to stress. J Leukoc Biol 82:204\u2013212","journal-title":"J Leukoc Biol"},{"key":"130_CR14","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/cc6164","volume":"12","author":"C Bopp","year":"2008","unstructured":"Bopp C, Bierhaus A, Hofer S, Bouchon A, Nawroth PP, Martin E, Weigand MA (2008) Bench-to-bedside review: the inflammation-perpetuating pattern-recognition receptor RAGE as a therapeutic target in sepsis. Crit Care 12:201","journal-title":"Crit Care"},{"key":"130_CR15","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.2337\/db07-1808","volume":"57","author":"A Soro-Paavonen","year":"2008","unstructured":"Soro-Paavonen A, Watson AM, Li J, Paavonen K, Koitka A, Calkin AC, Barit D, Coughlan MT, Drew BG, Lancaster GI, Thomas M, Forbes JM, Nawroth PP, Bierhaus A, Cooper ME, Jandeleit-Dahm KA (2008) Receptor for advanced glycation end products (RAGE) deficiency attenuates the development of atherosclerosis in diabetes. Diabetes 57:2461\u20132469","journal-title":"Diabetes"},{"key":"130_CR16","doi-asserted-by":"crossref","unstructured":"Pellegrini M, Nicolay U, Lindert K, Groth N, Della Cioppa G (2009) MF59-adjuvanted versus non-adjuvanted influenza vaccines: Integrated analysis from a large safety database. Vaccine [Epup ahead of print] http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=19751689","DOI":"10.1016\/j.vaccine.2009.08.101"},{"key":"130_CR17","unstructured":"WHO (2003) Update: cardiac-related events during the civilian smallpox vaccination program\u2013United States, 2003. MMWR Morb Mortal Wkly Rep 52:492-496 http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12809110"},{"key":"130_CR18","unstructured":"WHO (2003) Cardiac deaths after a mass smallpox vaccination campaign\u2014New York City, 1947. MMWR Morb Mortal Wkly Rep 52:933\u2013936"},{"key":"130_CR19","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s00430-007-0042-5","volume":"196","author":"J Cinatl Jr","year":"2007","unstructured":"Cinatl J Jr, Michaelis M, Doerr HW (2007) The threat of avian influenza A (H5N1). Part I: epidemiologic concerns and virulence determinants. Med Microbiol Immunol 196:181\u2013190","journal-title":"Med Microbiol Immunol"},{"key":"130_CR20","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s00430-007-0052-3","volume":"196","author":"J Cinatl Jr","year":"2007","unstructured":"Cinatl J Jr, Michaelis M, Doerr HW (2007) The threat of avian influenza A (H5N1). Part IV: development of vaccines. Med Microbiol Immunol 196:213\u2013225","journal-title":"Med Microbiol Immunol"},{"key":"130_CR21","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s00430-009-0118-5","volume":"198","author":"M Michaelis","year":"2009","unstructured":"Michaelis M, Doerr HW, Cinatl J Jr (2009) Novel swine-origin influenza A virus in humans: another pandemic knocking at the door. Med Microbiol Immunol 198:175\u2013183","journal-title":"Med Microbiol Immunol"},{"key":"130_CR22","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1183\/09031936.00135306","volume":"30","author":"A Ortqvist","year":"2007","unstructured":"Ortqvist A, Granath F, Askling J, Hedlund J (2007) Influenza vaccination and mortality: prospective cohort study of the elderly in a large geographical area. Eur Respir J 30:414\u2013422","journal-title":"Eur Respir J"},{"key":"130_CR23","doi-asserted-by":"crossref","first-page":"518","DOI":"10.7326\/0003-4819-123-7-199510010-00008","volume":"123","author":"PA Gross","year":"1995","unstructured":"Gross PA, Hermogenes AW, Sacks HS, Lau J, Levandowski RA (1995) The efficacy of influenza vaccine in elderly persons. A meta-analysis and review of the literature. Ann Intern Med 123:518\u2013527","journal-title":"Ann Intern Med"},{"key":"130_CR24","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/S0140-6736(05)67339-4","volume":"366","author":"T Jefferson","year":"2005","unstructured":"Jefferson T, Rivetti D, Rivetti A, Rudin M, Di Pietrantonj C, Demicheli V (2005) Efficacy and effectiveness of influenza vaccines in elderly people: a systematic review. Lancet 366:1165\u20131174","journal-title":"Lancet"},{"key":"130_CR25","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1016\/S0264-410X(02)00041-5","volume":"20","author":"T Vu","year":"2002","unstructured":"Vu T, Farish S, Jenkins M, Kelly H (2002) A meta-analysis of effectiveness of influenza vaccine in persons aged 65\u00a0years and over living in the community. Vaccine 20:1831\u20131836","journal-title":"Vaccine"},{"key":"130_CR26","doi-asserted-by":"crossref","first-page":"5567","DOI":"10.1016\/j.vaccine.2008.08.003","volume":"26","author":"AG Jansen","year":"2008","unstructured":"Jansen AG, Sanders EA, Nichol KL, van Loon AM, Hoes AW, Hak E (2008) Decline in influenza-associated mortality among Dutch elderly following the introduction of a nationwide vaccination program. Vaccine 26:5567\u20135574","journal-title":"Vaccine"},{"key":"130_CR27","doi-asserted-by":"crossref","first-page":"7313","DOI":"10.1016\/j.vaccine.2007.08.039","volume":"25","author":"J Puig-Barbera","year":"2007","unstructured":"Puig-Barbera J, Diez-Domingo J, Varea AB, Chavarri GS, Rodrigo JA, Hoyos SP, Vidal DG (2007) Effectiveness of MF59-adjuvanted subunit influenza vaccine in preventing hospitalisations for cardiovascular disease, cerebrovascular disease and pneumonia in the elderly. Vaccine 25:7313\u20137321","journal-title":"Vaccine"},{"key":"130_CR28","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S1473-3099(09)70233-6","volume":"9","author":"C Warren-Gash","year":"2009","unstructured":"Warren-Gash C, Smeeth L, Hayward AC (2009) Influenza as a trigger for acute myocardial infarction or death from cardiovascular disease: a systematic review. Lancet Infect Dis 9:601\u2013610","journal-title":"Lancet Infect Dis"}],"container-title":["Medical Microbiology and Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00430-009-0130-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00430-009-0130-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00430-009-0130-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T22:11:41Z","timestamp":1559081501000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00430-009-0130-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10,23]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["130"],"URL":"https:\/\/doi.org\/10.1007\/s00430-009-0130-9","relation":{},"ISSN":["0300-8584","1432-1831"],"issn-type":[{"value":"0300-8584","type":"print"},{"value":"1432-1831","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,10,23]]}}}